PE Ratio
N/A
Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| PE Ratio | - | – | – | – | – | – | – | – | |
| Price | $430.36 | -0.3% | -13.8% | -7.9% | -26.1% | +2.7% | +213.2% | +406.3% | |
| TTM Revenue | $1.28B | +13.4% | – | +13.4% | – | +149.0% | +100.0% | +100.0% | |
| TTM EPS | -$12.88 | -0.7% | – | -0.7% | – | -0.3% | +30.9% | +11.8% | |
| 18.99 | -0.3% | -13.8% | -7.9% | -14.0% | +24.9% | -83.4% | +211.3% | ||
| 7.74 | -0.4% | -13.9% | -8.0% | -44.2% | -39.7% | – | – | ||
| $9.45B | -0.3% | -14.4% | -8.3% | -25.4% | +8.1% | +289.7% | +732.9% | ||
| -29.44 | +0.3% | +14.4% | +8.3% | +30.6% | -3.0% | -322.4% | -514.6% | ||
| Market Cap | $10B | -0.3% | -13.8% | -7.9% | -25.3% | +4.5% | +291.3% | +593.8% |
Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 3.62 | N/A |
Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 0.92 | N/A |
History
| Date | Value | Change |
|---|---|---|
| 2.17 | - |
Formula
Data Sources & References
- MDGL Official Website www.madrigalpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828026009514/0001628280-26-009514-index.htm
- MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
- MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl
